Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
21.45
-0.31 (-1.42%)
At close: Sep 28, 2026, 4:00 PM EDT
21.40
-0.05 (-0.23%)
After-hours: Sep 28, 2026, 7:30 PM EDT
Tyra Biosciences Market Cap
Tyra Biosciences has a market cap or net worth of $1.47 billion as of September 28, 2026. Its market cap has increased by 113.35% in one year.
Market Cap
1.47B
Enterprise Value
1.13B
1-Year Change
113.35%
Ranking
Category
Stock Price
$21.45
ChartMarket Cap Chart
Since the IPO on September 15, 2021, Tyra Biosciences's market cap has increased from $654.64M to $1.47B, an increase of 125.29%. That is a compound annual growth rate of 17.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 1.47B | 5.11% |
| Dec 31, 2025 | 1.40B | 91.90% |
| Dec 31, 2024 | 731.18M | 22.61% |
| Dec 29, 2023 | 596.34M | 87.61% |
| Dec 30, 2022 | 317.87M | -44.42% |
| Dec 31, 2021 | 571.90M | -12.64% |
| Sep 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AnaptysBio | 1.53B |
| Taysha Gene Therapies | 1.52B |
| Inhibrx Biosciences | 1.52B |
| Innoviva | 1.49B |
| Maze Therapeutics | 1.47B |
| Kailera Therapeutics | 1.46B |
| Omeros | 1.45B |
| Ultragenyx Pharmaceutical | 1.40B |